(Q44715970)

5 December 2017

title

An open-label study investigating the efficacy and safety of 12-96 weeks of telmisartan treatment in patients with hypertension (English)

1 reference

5 December 2017

C Ingino

1

1 reference

5 December 2017

C Farsang

series ordinal

2

1 reference

5 December 2017

A Laucevicius

series ordinal

3

1 reference

5 December 2017

M Bergovec

series ordinal

4

1 reference

5 December 2017

publication date

1 November 2003

1 reference

Journal of International Medical Research

5 December 2017

published in

1 reference

5 December 2017

volume

31

1 reference

5 December 2017

issue

6

1 reference

5 December 2017

page(s)

561-574

1 reference

Organ protection and optimal blood pressure control

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Sodium-lithium countertransport: physiology and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Angiotensin receptor blocker selectivity at the AT1- and AT2-receptors: conceptual and clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Beyond blood pressure: new roles for angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Angiotensin-converting enzyme inhibitors and cough: a prospective evaluation in hypertension and in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Angiotensin II receptor blockade and end-organ protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Comparative safety and tolerability of angiotensin II receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Telmisartan: a review of its use in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Long-term exposure to telmisartan as monotherapy or combination therapy: efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

ABPM comparison of the anti-hypertensive profiles of telmisartan and enalapril in patients with mild-to-moderate essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Comparison of a fixed-dose combination of 40 mg telmisartan plus 12.5 mg hydrochlorothiazide with 40 mg telmisartan in the control of mild to moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Compliance with antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Hypertension and current issues in compliance and patient outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

Compliance and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100613

10.1177/147323000303100613

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference